Belgium· BE-AMP-SAM180607-00
Peditrace
A elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente product containing zinc chloride, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente is registered in 11 of 19 countries.
Countries holding a registration under ATC B05XA31 (elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente · ATC B05XA31
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Zinc Chloride
- Manufacturer
- Fresenius Kabi
- Country
- Belgium (BE)
- ATC code
- B05XA31
- ATC class
- Elektrolyte, Kombinationen mit anderen Arzneistoffen, inkl. reine Spurenelemente
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1344092
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
102 interactions on record for elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente · interactions on record
102 records
- 4 severe
- 12 moderate
- 86 minor
Most severe, free to view
- RaltegravirJ05AJ01severe
- ElvitegravirJ05AJ02severe
- RaltegravirJ05AX08severe
- ElvitegravirJ05AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States(Re) Setting 100% mineral Powder Deep Broad Spectrum SPF 35Supergoop, LLC
- GermanyBiolectraHermes Arzneimittel Gmbh
- United KingdomAntipeol ointmentAspar Pharmaceuticals Ltd
- Japan亜鉛華日興製薬
- NetherlandsWilzin 25 mg, harde capsulesOrphan Europe SARL
- PolandMaść cynkowaZakład Farmaceutyczny "Amara" Sp. z o.o.
- FranceEFFIZINC 15 mg, géluleEXPANSCIENCE
- FinlandVetzin vet.Vepidan Aps
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Labisan, Zink Aguettant
- Germany · Biolectra, Cefazink
- Denmark · Zipzoc
- Spain · Pasta Lassar Imba
- Finland · Zipzoc
- France · Effizinc, Oligosol
- United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
- Greece · Zincalto, Zinctin
- Ireland · Caldease, Zinc Ovelle
- Iceland · Wilzin
- Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
- Liechtenstein · Wilzin
- Luxembourg · Cefazink, Oligosol
- Latvia · Cinka Rff
- Netherlands · Daro Zinkzalf, Zinkolie
- Norway · Wilzin
- Poland · Maść Cynkowa,, Maść Z Tlenkiem Cynku
- Portugal · Halibut, Lassadermil
- Sweden · Zipzoc
- Slovakia · Tekutý Púder
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5417252-031e-4ca8-bc9b-deba1f5ae310 GET /v1/drugs/c5417252-031e-4ca8-bc9b-deba1f5ae310?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Peditrace",
"name_fr": "Peditrace",
"name_nl": "Peditrace",
"amp_code": "SAM180607-00",
"strengths": [
"521.0000",
"1.3100",
"126.0000",
"6.6600",
"53.7000",
"3.6000"
],
"pack_count": 1,
"substances": [
"Zinc Chloride",
"Potassium Iodide",
"Sodium Fluoride",
"Sodium Selenite",
"Copper (II) Chloride dihydrate",
"Manganese Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Electrolytes in Combination with Other Drugs",
"authorisation_numbers": [
"BE180607"
]
}See everything about elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.